2型糖尿病合并血管并发症患者的同型半胱氨酸与血糖波动的相关性研究

Abstract
Figure/Table
References (31)
Related Citation (15)

Download: PDF (422 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the relationship between homocysteine (Hcy) and blood glucose fluctuations in patients with type 2 diabetes with vascular complications. Methods A retrospective analysis of the clinical data of 497 patients with type 2 diabetes who were admitted to the Affiliated Hospital of Xuzhou Medical University from July 2017 to April 2019. According to the presence or absence of vascular complications, the selected subjects were divided into group A (without vascular complications, 162 cases), and group B (with vascular complications, 335 cases). In addition, the patients were divided into four groups according to the Hcy quartile. Among them, Hcy≤11.0 μmol/L was the Q1 group (103 cases), 11.0 μmol/L＜Hcy≤14.2 μmol/L was the Q2 group (157 cases), 14.2 μmol/L <Hcy≤19.0 μmol/L was the Q3 group (121 cases), and Hcy>19.0 μmol/L was the Q4 group (116 cases). The relative indicators of blood glucose fluctuations among the groups were compared. Results The age, course of disease, systolic blood pressure (SBP), Hcy, maximum blood glucose fluctuation range (LAGE), postprandial blood glucose fluctuation range (PPGE), and average blood glucose standard deviation (SDBG) in group B were higher than those in group A, and the differences were statistically significant (P ＜ 0.05). There were statistically significant differences in age, course of disease, SBP, SDBG, MBG, LAGE, HOMA-β, and HbA1c in the Q1-Q4 groups (P ＜ 0.05). Among them, age, course of disease, HbA1c, SDBG, MBG, LAGE of Q4 group were higher than those of the other three groups, Q3 group was higher than Q1, Q2 group, Q2 group was higher than Q1 group, and the differences were statistically significant (P ＜ 0.05). SBP of Q4 group was higher than Q1 and Q3 group, lower than Q2 group; Q3 group was higher than Q1 group, lower than Q2 group; Q2 group was higher than Q1 group, and the differences were statistically significant (P ＜ 0.05). HOMA-β in Q4 group were higher than Q1 group, lower than Q2 and Q3 group; Q3 group was higher than Q1 group, lower than Q2 group, Q2 group was higher than Q1 group, and the differences were statistically significant (P ＜ 0.05). Correlation studies showed that Hcy was negatively correlated with body mass index, diastolic blood pressure, and total cholesterol (P ＜ 0.05); it was positively correlated with age, SBP, HbA1c, LAGE, MBG, fasting blood glucose, PPGE, SDBG, and the course of diabetes (P ＜ 0.05). Conclusion Patients with type 2 diabetes have large fluctuations in blood glucose and increased Hcy, suggesting that it may increase the risk of diabetes complicated with vascular complications.

Key words： Diabetes Vascular complications Homocysteine Blood glucose fluctuations

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CAI Qian1 LI Yuncheng2 LI Wei2

Cite this article:

CAI Qian1 LI Yuncheng2 LI Wei2. Correlation between homocysteine and blood glucose fluctuation in patients with type 2 diabetes with vascular complications[J]. 中国医药导报, 2021, 18(15): 71-74.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I15/71

[1] 吕喆，陈亦棋，沈丽君，等.2型糖尿病患者糖尿病视网膜病变风险预测模型的建立和初步验证[J].中华眼底病杂志，2017，33（3）：257-261.
[2] 刘娜，郭志新.2型糖尿病合并多发性骨髓瘤继发Fanconi综合征一例[J].中华糖尿病杂志，2018，10（5）：364-366.
[3] 世界卫生组织（WHO）.糖尿病诊断标准[S].1999.
[4] 中华医学会糖尿病学会.中国2型糖尿病防治指南：2010年版[M].北京：北京大学医学出版社，2011.
[5] 中华医学会内分泌学分会脂代谢学组.中国2型糖尿病合并血脂异常防治专家共识（2017年修订版）[J].中华内分泌代谢杂志，2017，33（11）：925-936.
[6] 陆静毅，马晓静，周健，等.持续葡萄糖监测测定的目标范围内时间与2型糖尿病视网膜病变的相关性研究[J].中华内科杂志，2019，58（1）：65.
[7] 张永忠，于新龙，魏海青.促甲状腺激素、同型半胱氨酸与2型糖尿病患者颈动脉内中膜厚度相关性研究[J].河北医科大学学报，2020，41（5）：510-514.
[8] 王辰光，石晓琪，蔡轶珩，等.106例2型糖尿病患者舌色分布特点及相关因素分析[J].现代中西医结合杂志，2020，29（20）：2184-2187，2216.
[9] 徐保振，高玉伟，王兴华，等.依帕司他片在老年2型糖尿病肾病患者治疗中的应用[J].中国老年学杂志，2020， 40（13）：2731-2733.
[10] 肖建中.钠-葡萄糖共转运蛋白2抑制剂减少糖尿病肾脏事件：作用机制与临床转化[J].中华糖尿病杂志，2018， 10（2）：111-112.
[11] 杜珂珂，徐峰，李喜梅，等.血清视黄醇结合蛋白4及血清Lipasin与妊娠糖尿病血管并发症相关性分析[J].中华内分泌外科杂志，2019，13（2）：150-153.
[12] 宋雯婧，郭青玉，曹白露，等.2型糖尿病患者泌汗功能与心血管自主神经病变的相关性分析[J].中华糖尿病杂志，2019，11（5）：353-358.
[13] Demirsoy ■H，Ertural DY，Balci ■，et al. Profiles of Circulating MiRNAs Following Metformin Treatment in Patients with Type 2 Diabetes [J]. J Med Biochem，2018，37（4）：499-506.
[14] 陆冰，潘晓东，周林赟，等.老年高血压患者同型半胱氨酸水平与脑白质病变分级及认知功能的相关性研究[J].中华老年医学杂志，2019，38（3）：251-254.
[15] 傅健钊，刘勇波，陈燕如，等.血清同型半胱氨酸、β2微球蛋白及视黄醇结合蛋白联合检测对2型糖尿病早期肾损害的诊断价值[J].现代医院，2020，20（11）：1713-1716.
[16] 孙晶，曹白露，李柯，等.2型糖尿病患者血糖波动与泌汗功能的相关性[J].中华糖尿病杂志，2018，10（7）：476-481.
[17] 缪凌枫，钱玲玲，王如兴.血糖波动相关性心律失常的研究进展[J].中华心血管病杂志，2019，47（2）：157-160.
[18] 王莹，吴东红，程瑶，等.血清胱抑素C与25-羟维生素D及同型半胱氨酸在糖尿病肾病患者中的临床应用价值[J].中国医药，2020，15（11）：1737-1739.
[19] 毕雪斐，刘达瑾，候书贤，等.红细胞分布宽度与合并2型糖尿病的冠心病病理变化及严重程度相关性研究[J].中西医结合心脑血管病杂志，2020，18（15）：2467-2472.
[20] 广圣芳，翟荣荣，王璐，等.血清同型半胱氨酸，胱抑素C，超氧化物歧化酶对2型糖尿病肾病的早期诊断价值[J].中国实验诊断学，2020，24（7）：1114-1117.
[21] 刘小平，杨军，何伟，等.脂代谢指标及血清CysC、Hcy在高血压合并2型糖尿病患者中的变化研究[J].中国医学创新，2019，16（20）：127-130.
[22] 李晓青.2型糖尿病合并高同型半胱氨酸血症与动脉硬化性脑梗死的关系研究进展[J].实用心脑肺血管病杂志，2020，28（7）：1-5.
[23] 陈斌，齐晓玲，徐礼五，等.β2MG、Hcy、CysC检测在2型糖尿病视网膜病变诊断中的价值[J].分子诊断与治疗杂志，2020，12（6）：818-821，826.
[24] 齐小健.联合检测血清同型半胱氨酸、胱抑素C及尿β2微球蛋白在诊断糖尿病肾病中的临床应用价值[J].中国现代医生，2021，59（3）：142-144.
[25] 杨平，廖萍，伍文娟.血清同型半胱氨酸、C反应蛋白与2型糖尿病伴脑梗死患者颈动脉粥样硬化的关系[J].中国医药导报，2019，16（5）：126-129，141.
[26] 朱新建，董月华，李鹏宇，等.血清淀粉样蛋白A对2型糖尿病患者不良心血管事件的影响[J].武警医学，2020， 31（6）：516-519.
[27] 杨林飞，陈敏，张婷，等.同型半胱氨酸水平与高血压患者冠状动脉病变程度和性质的关系[J].中华高血压杂志，2018，26（6）：586-589.
[28] 马文莉.MPV、HbA1c及hs-CRP监测在2型糖尿病微血管病变中的临床分析[J].中国医药科学，2020，10（9）：157-160.
[29] Verma S，Alam R，Ahmad I，et al. Effect of glycemic control and disease duration on cardiac autonomic function and oxidative stress in type 2 diabetes mellitus[J]. J Diabetes Metab Disord，2018，17（2）：149-158.
[30] 梁碧瑜，阮世冲，林中军，等.血清Chemerin、Adropin水平与2型糖尿病合并高同型半胱氨酸血症的相关性分析[J].中国当代医药，2021，28（2）：68-70.
[31] 梁琦琦，韩笑，李静文，等.2型糖尿病病人颈动脉斑块形成的危险因素分析[J].中西医结合心脑血管病杂志，2020，18（17）：2935-2937.